Must medications be discontinued prior to a Multiple Sleep Latency Test (MSLT) study?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Yes, you typically need to stop certain medications before a Multiple Sleep Latency Test (MSLT), as they can interfere with test results by artificially altering your sleep patterns or ability to fall asleep. Medications that affect sleep or alertness should be discontinued, including stimulants like modafinil, methylphenidate, and amphetamines; antidepressants such as SSRIs, SNRIs, and tricyclics; antihistamines; benzodiazepines; sleep aids; and certain pain medications. The withdrawal period varies by medication but generally ranges from 2 weeks to a month before the test, with some medications like fluoxetine requiring a longer withdrawal period of 6 weeks 1.

Some key points to consider when stopping medications for an MSLT include:

  • Never stop prescription medications without consulting your doctor first, as some medications require gradual tapering to avoid withdrawal symptoms 2.
  • The sleep specialist will provide specific instructions about which medications to stop and when.
  • It's crucial to follow these instructions precisely to ensure accurate test results.
  • If you have concerns about stopping any medication, discuss alternative approaches with your sleep specialist and prescribing physician.

The most recent and highest quality study on this topic, published in 2020, found that discontinuing rapid eye movement-suppressing antidepressants (REMS-ADs) prior to MSLT increased the number of sleep-onset rapid eye movement periods and reduced mean sleep latency 1. This study suggests that clinicians should preferably withdraw REMS-ADs before MSLT, and if this is not done, the test interpretation should include a statement regarding the potential effect of the drugs on the results.

References

Research

Advance taper of antidepressants prior to multiple sleep latency testing increases the number of sleep-onset rapid eye movement periods and reduces mean sleep latency.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.